Saturday, 17 October 2026European Markets

BOUSSARD GAVAUDAN Stock Impressive Jump On Tuesday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with BOUSSARD GAVAUDAN (BGHL.AS) rising 11.21% to €23.80 on Tuesday, after three successive sessions in a row of losses. AEX-Index jumped 1.07% to €779.81, following the last session's downward trend on what was an all-around positive trend exchanging session today.

BOUSSARD GAVAUDAN's last close was €21.40, 10.83% below its 52-week high of €24.00.

About BOUSSARD GAVAUDAN

Boussard & Gavaudan Holding Limited is a closed-ended balanced fund of funds launched and managed by Boussard & Gavaudan Asset Management, LP. It invests in a fund which invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in units of BG Umbrella Fund Plc - BG Fund, a feeder fund to BG Master Fund Plc, which in turn invests in value stocks of companies and fixed income securities. The fund employs both fundamental and quantitative analysis with a bottom-up security selection approach to create its portfolio. It employs multiple strategies including convertible bond arbitrage, volatility arbitrage, gamma trading, merger arbitrage, special situations, equity long/short, value, capital structure arbitrage, credit long/short, and restructuring/distressed securities strategies to make its investments. Boussard & Gavaudan Holding Limited was formed on October 3, 2006 and is domiciled in the Channel Islands.

Earnings Per Share

As for profitability, BOUSSARD GAVAUDAN has a trailing twelve months EPS of €2.73.

PE Ratio

BOUSSARD GAVAUDAN has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing €8.71 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -5.21%.

More news about BOUSSARD GAVAUDAN (BGHL.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com